PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)

Q: What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in Q4 2025?

62 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 69353Y103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, $0.00001 par value per share
Shares outstanding: 53,625,367
Total 13F shares: 37,422,687
Share change: -94,369
Total reported value: $46,777,977
Price per share: $1.25
Number of holders: 62
Value change: -$174,801
Number of buys: 30
Number of sells: 27

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
INTERWEST PARTNERS X LP	3/4/5	10%+ Owner	— class O/S missing	4,502,480	$10,040,531	—	13 Jul 2021	3/4/5
ORBIMED ADVISORS LLC	13F 3/4/5	Company · 10%+ Owner	9.3% from 3/4/5	5,975,291	$8,365,407	—	30 Sep 2025	13F 3/4/5
BML Capital Management, LLC	13F	Company	9.9%	5,292,000	$7,408,800	—	30 Sep 2025	13F
TANG CAPITAL MANAGEMENT LLC	13D/G 13F	Company	8.9%	4,720,357	$6,702,907	$0	16 Sep 2025	13D/G 13F
BML Investment Partners, L.P.	13D/G	—	9.9%	5,292,000	$6,615,000	+$2,527,616	31 Dec 2025	13D/G
ArrowMark Colorado Holdings LLC	13F 13D/G	Company	5.8% from 13D/G	3,301,341	$4,621,877	—	30 Sep 2025	13F 13D/G
Sio Capital Management, LLC	13F	Company	4.9%	2,636,548	$3,691,167	—	30 Sep 2025	13F
Euclidean Capital LLC	13F 3/4/5	Company · 10%+ Owner	4.9%	2,627,643	$3,678,700	—	30 Sep 2025	13F 3/4/5
VANGUARD GROUP INC	13F	Company	4%	2,163,027	$3,028,239	—	30 Sep 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	3.9%	2,066,137	$2,891,000	—	30 Sep 2025	13F
Thilo Schroeder	3/4/5	Director	— class O/S missing	1,101,283	$2,455,861	—	06 Oct 2021	3/4/5
Stonepine Capital Management, LLC	13F	Company	2.6%	1,370,139	$1,918,195	—	30 Sep 2025	13F
BlackRock, Inc.	13F	Company	2.1%	1,104,140	$1,545,795	—	30 Sep 2025	13F
MARSHALL WACE, LLP	13F	Company	1.1%	612,626	$857,677	—	30 Sep 2025	13F
Aldebaran Capital, LLC	13F	Company	0.94%	504,128	$705,779	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	431,820	$604,698	—	30 Sep 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.78%	417,900	$585,060	—	30 Sep 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.71%	382,050	$534,870	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.71%	380,813	$533,138	—	30 Sep 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.6%	320,653	$448,914	—	30 Sep 2025	13F
Walleye Capital LLC	13F	Company	0.52%	278,459	$389,843	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.5%	269,621	$377,469	—	30 Sep 2025	13F
RBF Capital, LLC	13F	Company	0.46%	245,561	$343,785	—	30 Sep 2025	13F
Peapod Lane Capital LLC	13F	Company	0.38%	202,784	$283,908	—	30 Sep 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.38%	201,498	$282,097	—	30 Sep 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.36%	193,153	$270,414	—	30 Sep 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.32%	170,802	$239,123	—	30 Sep 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.3%	162,496	$227,495	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	0.29%	157,578	$220,609	—	30 Sep 2025	13F
EVOKE WEALTH, LLC	13F	Company	0.25%	133,122	$186,371	—	30 Sep 2025	13F
Assenagon Asset Management S.A.	13F	Company	0.23%	123,092	$172,329	—	30 Sep 2025	13F
ADAR1 Capital Management, LLC	13F	Company	0.19%	101,008	$141,411	—	30 Sep 2025	13F
Ikarian Capital, LLC	13F	Company	0.18%	97,500	$136,500	—	30 Sep 2025	13F
Leila Alland	3/4/5	Chief Medical Officer	— class O/S missing	45,909	$102,377	—	15 Sep 2023	3/4/5
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.13%	72,089	$100,925	—	30 Sep 2025	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.13%	71,006	$99,408	—	30 Sep 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.13%	68,668	$96,135	—	30 Sep 2025	13F
ALGERT GLOBAL LLC	13F	Company	0.12%	62,020	$87,000	—	30 Sep 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.1%	55,718	$78,005	—	30 Sep 2025	13F
Rangeley Capital, LLC	13F	Company	0.08%	45,500	$63,700	—	30 Sep 2025	13F
Cubist Systematic Strategies, LLC	13F	Company	0.08%	43,869	$61,417	—	30 Sep 2025	13F
XTX Topco Ltd	13F	Company	0.08%	42,762	$59,867	—	30 Sep 2025	13F
Velan Capital Investment Management LP	13F	Company	0.07%	35,000	$49,000	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0.06%	32,395	$45,353	—	30 Sep 2025	13F
HSBC HOLDINGS PLC	13F	Company	0.06%	30,891	$43,093	—	30 Sep 2025	13F
BARCLAYS PLC	13F	Company	0.05%	27,536	$38,551	—	30 Sep 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	25,634	$35,888	—	30 Sep 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.04%	20,741	$29,000	—	30 Sep 2025	13F
CITIGROUP INC	13F	Company	0.04%	19,297	$27,016	—	30 Sep 2025	13F
Pathstone Holdings, LLC	13F	Company	0.03%	17,487	$24,482	—	30 Sep 2025	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) as of Q4 2025

As of 31 Dec 2025, PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,422,687 shares. The largest 10 holders included BML Capital Management, LLC, ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Stonepine Capital Management, LLC, and BlackRock, Inc.. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

-1

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.